Highlights HHS-OIG recently released Advisory Opinion No. 24-12,  a favorable opinion involving a drug manufacturer’s patient ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

The US Food and Drug Administration (FDA) rejected three prior regulatory applications before granting approval.

On Friday, the U.S. Judicial Panel on Multidistrict Litigation ordered nearly 70 lawsuits be coordinated beefore U.S.

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

A private firm that offers GPS tracking services for offenders on bail has collapsed, leaving police, justice authorities and ...

American importers will pay a new 25 percent tax on goods from Canada and Mexico and a 10 percent levy on products from China ...

Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug ...

Keeping a lid on drug prices is proving costly for ambitions to turn the UK into a life sciences superpower ...

Tariffs on Canadian goods are expected to have far-reaching effects on the City of Edmonton's budget. Local leaders and city ...

The research is based on a review of electronic health ... on "the most critical areas of the business" — including weight loss and diabetes drugs, the company confirmed to CNBC on Monday.